Adjuvia Therapeutics closes $8 million in Seed financing to advance ATI-105, a novel mitochondrial disease therapy, into Phase 1 clinical trials.
Amount Raised
$8 Million
Round Type
Seed
San FranciscoBiotechnologyHealth CareMedicalTherapeuticsDescription
Adjuvia Therapeutics has successfully raised $8 million in a Series Seed financing round. The funds will be used to advance ATI-105, a novel therapy for mitochondrial diseases, into Phase 1 clinical trials. This financing marks an important step in the company's development of innovative treatments. The company aims to address unmet medical needs in this area.
Quick answer
Adjuvia Therapeutics raised $8 Million in a Seed round, dated July 29, 2026. Adjuvia Therapeutics is based in San Francisco, California, United States.
- How much did Adjuvia Therapeutics raise?
- Adjuvia Therapeutics raised $8 Million in a Seed round on July 29, 2026.
- What does Adjuvia Therapeutics do?
- Adjuvia Therapeutics is focused on developing innovative therapies for mitochondrial diseases.
- Where is Adjuvia Therapeutics based and how big is it?
- Adjuvia Therapeutics is based in San Francisco, California, United States. Fundz records about 8 employees.
- Who are the decision-makers at Adjuvia Therapeutics?
- Fundz holds 1 contact at Adjuvia Therapeutics, including the Chief Operating Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Adjuvia Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Navion Neurosciences raised $11M (Seed) on September 9, 2026.
- Cloverleaf Bio raised $33M (Seed) on September 8, 2026.
- N-Power Medicine raised $32M (Series B) on September 1, 2026.
- Scancell Holdings PLC raised $39M (Post-IPO Equity) on July 23, 2026.
- Georgiamune raised $93M on July 16, 2026.
- Imagion Biosystems raised $2.8M (Post-IPO Equity) on June 25, 2026.
Who to call at Adjuvia Therapeutics, and when
A new round usually means Adjuvia Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Adjuvia Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Adjuvia Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Adjuvia Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Adjuvia Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Adjuvia Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.